Accelerated FDA Approvals of Immunotherapy Treatments Are Accelerating

Everyday something new is discovered that explains cancer behavior, including proliferation, response to treatment, resistance to treatment, metastasis, recurrence, etc.

Today we have several news, including one that might have cleared a puzzle regarding a continuous growth of colon cancer after oncologists block a well known signaling molecule recognized as playing a major role in making, not breaking the cancer.

We also have news about accelerated FDA approval for:

1. An immunotherapy from Genentech for advanced bladder cancer, which did not have any new drug approved for the past 30 years and,

This content is for paid subscribers.
Please click here to subscribe or here to log in.